{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:58:51Z","timestamp":1787896731638,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Projects in Shaanxi Province","award":["2023-YBSF-599"],"award-info":[{"award-number":["2023-YBSF-599"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-024-03210-y","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:21:36Z","timestamp":1738999296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["YTHDF2 mediates the protective effects of MG53 on myocardial infarction injury via recognizing the m6A modification of MG53"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhaojie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"issue":"2","key":"3210_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","volume":"104","author":"S Barrere-Lemaire","year":"2024","unstructured":"Barrere-Lemaire S, Vincent A, Jorgensen C, Piot C, Nargeot J, Djouad F. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing. Physiol Rev. 2024;104(2):659\u2013725.","journal-title":"Physiol Rev"},{"issue":"5","key":"3210_CR2","doi-asserted-by":"publisher","first-page":"e2204999","DOI":"10.1002\/advs.202204999","volume":"10","author":"Q Sun","year":"2023","unstructured":"Sun Q, Ma H, Zhang J, You B, Gong X, Zhou X, et al. A self-sustaining antioxidant strategy for effective treatment of myocardial infarction. Adv Sci (Weinh). 2023;10(5):e2204999.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"3210_CR3","doi-asserted-by":"publisher","first-page":"e76476","DOI":"10.1136\/bmjopen-2023-076476","volume":"13","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Sheng Z, Che W, An S, Sun D, Zhai Z, et al. Design and rationale of the ATTRACTIVE trial: a randomised trial of intrAThrombus Thrombolysis versus aspiRAtion thrombeCTomy during prImary percutaneous coronary interVEntion in ST-segment elevation myocardial infarction patients with high thrombus burden. BMJ Open. 2023;13(11):e76476.","journal-title":"BMJ Open"},{"issue":"12","key":"3210_CR4","doi-asserted-by":"publisher","first-page":"101398","DOI":"10.1016\/j.cpcardiol.2022.101398","volume":"47","author":"A Schafer","year":"2022","unstructured":"Schafer A, Konig T, Bauersachs J, Akin M. Novel therapeutic strategies to reduce reperfusion Injury after Acute myocardial infarction. Curr Probl Cardiol. 2022;47(12):101398.","journal-title":"Curr Probl Cardiol"},{"issue":"7","key":"3210_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s12276-022-00800-5","volume":"54","author":"B Qi","year":"2022","unstructured":"Qi B, Song L, Hu L, Guo D, Ren G, Peng T, et al. Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis. Exp Mol Med. 2022;54(7):946\u201360.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3210_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ncb1812","volume":"11","author":"C Cai","year":"2009","unstructured":"Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, et al. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol. 2009;11(1):56\u201364.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3210_CR7","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1038\/s41467-019-12483-0","volume":"10","author":"Z Bian","year":"2019","unstructured":"Bian Z, Wang Q, Zhou X, Tan T, Park KH, Kramer HF, et al. Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function. Nat Commun. 2019;10(1):4659.","journal-title":"Nat Commun"},{"key":"3210_CR8","doi-asserted-by":"publisher","first-page":"1377025","DOI":"10.3389\/fphys.2024.1377025","volume":"15","author":"YF Wang","year":"2024","unstructured":"Wang YF, An ZY, Li JW, Dong ZK, Jin WL. MG53\/TRIM72: multi-organ repair protein and beyond. Front Physiol. 2024;15:1377025.","journal-title":"Front Physiol"},{"key":"3210_CR9","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1038\/ncomms5387","volume":"5","author":"Y Jia","year":"2014","unstructured":"Jia Y, Chen K, Lin P, Lieber G, Nishi M, Yan R, et al. Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nat Commun. 2014;5:4387.","journal-title":"Nat Commun"},{"issue":"1","key":"3210_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cvr\/cvr029","volume":"91","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, et al. MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res. 2011;91(1):108\u201315.","journal-title":"Cardiovasc Res"},{"key":"3210_CR11","doi-asserted-by":"publisher","first-page":"1295349","DOI":"10.3389\/fendo.2023.1295349","volume":"14","author":"Y Du","year":"2023","unstructured":"Du Y, Li T, Yi M. Is MG53 a potential therapeutic target for cancer? Front Endocrinol (Lausanne). 2023;14:1295349.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3210_CR12","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.2147\/IJGM.S435030","volume":"16","author":"SM Liu","year":"2023","unstructured":"Liu SM, Zhao Q, Li WJ, Zhao JQ. Advances in the study of MG53 in Cardiovascular Disease. Int J Gen Med. 2023;16:6073\u201382.","journal-title":"Int J Gen Med"},{"key":"3210_CR13","doi-asserted-by":"publisher","first-page":"596107","DOI":"10.3389\/fcvm.2020.596107","volume":"7","author":"H Xie","year":"2020","unstructured":"Xie H, Yan Z, Feng S, Zhu T, Zhu Z, Ni J, et al. Prognostic value of circulating MG53 levels in Acute myocardial infarction. Front Cardiovasc Med. 2020;7:596107.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"3210_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/FJC.0000000000001515","volume":"83","author":"D Li","year":"2024","unstructured":"Li D, Li L, Dong S, Yu Y, Zhang L, Jiang S. Alkylation Repair Homolog 5 regulates N(6)-methyladenosine (m6A) methylation of Mitsugumin 53 to attenuate myocardial infarction by inhibiting apoptosis and oxidative stress. J Cardiovasc Pharmacol. 2024;83(2):183\u201392.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"3210_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m(6)a RNA methylation. Nat Rev Genet. 2014;15(5):293\u2013306.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"3210_CR16","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","volume":"48","author":"H Zhang","year":"2020","unstructured":"Zhang H, Shi X, Huang T, Zhao X, Chen W, Gu N, et al. Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res. 2020;48(11):6251\u201364.","journal-title":"Nucleic Acids Res"},{"key":"3210_CR17","doi-asserted-by":"publisher","first-page":"105845","DOI":"10.1016\/j.phrs.2021.105845","volume":"174","author":"R Gong","year":"2021","unstructured":"Gong R, Wang X, Li H, Liu S, Jiang Z, Zhao Y, et al. Loss of m(6)a methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury. Pharmacol Res. 2021;174:105845.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3210_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3210_CR19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","volume":"41","author":"L Wang","year":"2023","unstructured":"Wang L, Dou X, Chen S, Yu X, Huang X, Zhang L, et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell. 2023;41(7):1294\u2013308.","journal-title":"Cancer Cell"},{"issue":"6","key":"3210_CR20","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1007\/s13577-023-00956-w","volume":"36","author":"X Cai","year":"2023","unstructured":"Cai X, Zou P, Hong L, Chen Y, Zhan Y, Liu Y, et al. RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m(6)a modification. Hum Cell. 2023;36(6):1948\u201364.","journal-title":"Hum Cell"},{"key":"3210_CR21","doi-asserted-by":"publisher","first-page":"113572","DOI":"10.1016\/j.biopha.2022.113572","volume":"154","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yao M, Jiang L, Wang L, Yang Y, Wang Q, et al. Dexmedetomidine attenuates myocardial ischemia\/reperfusion-induced ferroptosis via AMPK\/GSK-3beta\/Nrf2 axis. Biomed Pharmacother. 2022;154:113572.","journal-title":"Biomed Pharmacother"},{"key":"3210_CR22","doi-asserted-by":"publisher","first-page":"109464","DOI":"10.1016\/j.biopha.2019.109464","volume":"120","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu D, Hu H, Zhang P, Xie R, Cui W. HIF-1alpha\/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2019;120:109464.","journal-title":"Biomed Pharmacother"},{"key":"3210_CR23","doi-asserted-by":"crossref","unstructured":"Niu X, Zhang J, Ni J, Wang R, Zhang W, Sun S et al. Network pharmacology-based identification of major component of Angelica Sinensis and its action mechanism for the treatment of acute myocardial infarction. Biosci Rep, 2018,38(6).","DOI":"10.1042\/BSR20180519"},{"issue":"1","key":"3210_CR24","doi-asserted-by":"publisher","first-page":"2217033","DOI":"10.1080\/15592294.2023.2217033","volume":"18","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Cao Y, Yang Y, Wang S, Chen F. METTL3-mediated m(6)a modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p\/MDR1 axis. Epigenetics. 2023;18(1):2217033.","journal-title":"Epigenetics"},{"issue":"1","key":"3210_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-021-01871-4","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Tian L, Li Y, Wang J, Yan B, Yang L, et al. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res. 2021;40(1):80.","journal-title":"J Exp Clin Cancer Res"},{"key":"3210_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-1-4939-9500-4_23","volume":"1999","author":"M Zhang","year":"2019","unstructured":"Zhang M, Liu R, Wang F. Telomere and G-Quadruplex colocalization analysis by immunofluorescence fluorescence in situ hybridization (IF-FISH). Methods Mol Biol. 2019;1999:327\u201333.","journal-title":"Methods Mol Biol"},{"key":"3210_CR27","doi-asserted-by":"crossref","unstructured":"Zucha D, Kubista M, Valihrach L. Tutorial: guidelines for single-cell RT-qPCR. Cells, 2021,10(10).","DOI":"10.3390\/cells10102607"},{"issue":"1","key":"3210_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13287-020-1563-8","volume":"11","author":"Z Wen","year":"2020","unstructured":"Wen Z, Mai Z, Zhu X, Wu T, Chen Y, Geng D, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN\/AKT pathway. Stem Cell Res Ther. 2020;11(1):36.","journal-title":"Stem Cell Res Ther"},{"key":"3210_CR29","doi-asserted-by":"publisher","first-page":"644225","DOI":"10.3389\/fphar.2021.644225","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Yan M, Yang R, Qin X, Chen L, Li L, et al. Adiponectin attenuates lipopolysaccharide-induced apoptosis by regulating the Cx43\/PI3K\/AKT pathway. Front Pharmacol. 2021;12:644225.","journal-title":"Front Pharmacol"},{"key":"3210_CR30","doi-asserted-by":"crossref","unstructured":"Liu Y, Xing J, Li Y, Luo Q, Su Z, Zhang X et al. Chronic hypoxia-induced cirbp hypermethylation attenuates hypothermic cardioprotection via down-regulation of ubiquinone biosynthesis. Sci Transl Med, 2019,11(489).","DOI":"10.1126\/scitranslmed.aat8406"},{"issue":"4","key":"3210_CR31","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/cphy.c150006","volume":"5","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5(4):1841\u201375.","journal-title":"Compr Physiol"},{"issue":"1","key":"3210_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13578-021-00629-x","volume":"11","author":"W Zhong","year":"2021","unstructured":"Zhong W, Benissan-Messan DZ, Ma J, Cai C, Lee P. Cardiac effects and clinical applications of MG53. Cell Biosci. 2021;11(1):115.","journal-title":"Cell Biosci"},{"issue":"1","key":"3210_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12012-020-09609-y","volume":"21","author":"W Jiang","year":"2021","unstructured":"Jiang W, Liu M, Gu C, Ma H. The pivotal role of Mitsugumin 53 in Cardiovascular diseases. Cardiovasc Toxicol. 2021;21(1):2\u201311.","journal-title":"Cardiovasc Toxicol"},{"key":"3210_CR34","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.redox.2022.102357","volume":"54","author":"K Gumpper-Fedus","year":"2022","unstructured":"Gumpper-Fedus K, Park KH, Ma H, Zhou X, Bian Z, Krishnamurthy K, et al. MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress. Redox Biol. 2022;54:102357.","journal-title":"Redox Biol"},{"key":"3210_CR35","doi-asserted-by":"publisher","first-page":"868632","DOI":"10.3389\/fcvm.2022.868632","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, Park KH, Geng B, Chen P, Yang C, Jiang Q, et al. MG53 inhibits necroptosis through ubiquitination-dependent RIPK1 degradation for Cardiac Protection following Ischemia\/Reperfusion Injury. Front Cardiovasc Med. 2022;9:868632.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3210_CR36","doi-asserted-by":"publisher","first-page":"2271196","DOI":"10.1080\/10641963.2023.2271196","volume":"45","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou H, Wu J, Ye S. MG53 alleviates hypoxia\/reoxygenation-induced cardiomyocyte injury by succinylation and ubiquitination modification. Clin Exp Hypertens. 2023;45(1):2271196.","journal-title":"Clin Exp Hypertens"},{"key":"3210_CR37","doi-asserted-by":"publisher","first-page":"1018971","DOI":"10.3389\/fphys.2022.1018971","volume":"13","author":"B Xu","year":"2022","unstructured":"Xu B, Wang C, Chen H, Zhang L, Gong L, Zhong L, et al. Protective role of MG53 against ischemia\/reperfusion injury on multiple organs: a narrative review. Front Physiol. 2022;13:1018971.","journal-title":"Front Physiol"},{"issue":"1","key":"3210_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W. M(6)A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13(1):35.","journal-title":"J Hematol Oncol"},{"key":"3210_CR39","doi-asserted-by":"publisher","first-page":"174915","DOI":"10.1016\/j.ejphar.2022.174915","volume":"922","author":"Y Shao","year":"2022","unstructured":"Shao Y, Li M, Yu Q, Gong M, Wang Y, Yang X, et al. CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy. Eur J Pharmacol. 2022;922:174915.","journal-title":"Eur J Pharmacol"},{"key":"3210_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2023.06.001","volume":"181","author":"V Kmietczyk","year":"2023","unstructured":"Kmietczyk V, Oelschlager J, Gupta P, Varma E, Hartl S, Furkel J, et al. Ythdf2 regulates cardiac remodeling through its mRNA target transcripts. J Mol Cell Cardiol. 2023;181:57\u201366.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"3210_CR41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00395-024-01044-2","volume":"119","author":"GE Xu","year":"2024","unstructured":"Xu GE, Yu P, Hu Y, Wan W, Shen K, Cui X, et al. Exercise training decreases lactylation and prevents myocardial ischemia-reperfusion injury by inhibiting YTHDF2. Basic Res Cardiol. 2024;119(4):651\u201371.","journal-title":"Basic Res Cardiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03210-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-03210-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03210-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:21:45Z","timestamp":1738999305000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-03210-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3210"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-03210-y","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Xi\u2019an Medical College (XYLS2022221). All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}